Krystal Biotech, Inc. is a commercial-stage company focused on developing genetic medicines to address high unmet medical needs. Their mission is to develop and deliver redosable gene therapies for the treatment of severe, life-threatening, or rare diseases that have limited or no approved therapies. Krystal's first commercial product, VYJUVEK, is the pioneering redosable gene therapy designed to treat dystrophic epidermolysis bullosa. The company is advancing an integrated pipeline of genetic therapies aimed at correcting the root causes of serious and rare genetic diseases. Krystal utilizes a novel therapeutic platform based on a modified and engineered HSV-1 vector that is replication-defective and non-integrating, ensuring a safe and effective delivery of gene therapies. With two GMP facilities, Krystal is committed to the manufacturing and commercialization of transformative genetic medicines.
February 12
Join Krystal Biotech to spearhead Gene Therapy efforts in enhancing patient care for rare diseases.
January 25
Oversee office operations and support company processes for Krystal Biotech in France.
Remote Jobs at Krystal Biotech, Inc.